
Epigral Q4 FY25: Net profit up 13% at Rs 87 crore; Rs 3.5 per share final dividend declared
Chemical manufacturer Epigral has disclosed plans to expand its CPVC and Epichlorohydrin capacity, targeting completion in the first half of FY2027. This strategic expansion is anticipated to contribute significantly to the company's growth from FY2027 …